Mitsui Sumitomo plans to expand MS Amlin’s London capacity by 50% in 5 years: report
February 16 2024 by Mithun Varkey
-
Mitsui Sumitomo to offer Australia SME capacity to Argyle Insurance
- November 15
The multi-year agreement, starting January 1, 2025, will offer business insurance packages with an extended combined limit of up to US$4.52m.
-
Indian reinsurers shifting towards enhanced domestic capacity and innovation: J.B. Boda
- November 7
Domestic carriers are seeking partners who can offer capacity, support growth, advanced analytics and broad-based expertise, said Rohit Boda.
-
APAC cyber uptake still low despite softer pricing, ample capacity
- November 5
While carriers are developing a better understanding of cyber risk, there is a need for further education to address the protection gap, especially in emerging markets.
-
Expanding into non-ILS capital pools is a priority: MS Amlin
- November 4
William Ho, MS Amlin Asia Pacific CEO, discusses the evolving regional reinsurance landscape, the impact of recent cat losses, and the reinsurer’s strategic growth plans in APAC.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
